Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-22

Clinical Trial Update: Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

This is a Phase 2 study of Bendamustine hydrochloride in combination with Rituximab in patients with relapsed or refractory mantle cell lymphoma; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bendamustine Hydrochloride (bendamustine)
  • Rituximab (rituximab)

Snippet

Sponsor: Cephalon | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-10-22